Covina, Feb. 27, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the PARP Inhibitor Market size was valued at about USD 12.5 Billion in 2024 and expected to grow at CAGR of 18.30% to extend a value of USD 67.0 Billion by 2034.” What is PARP Inhibitor? Market Overview: PARP inhibitors are a class of medications that inhibit the activity of poly (ADP-ribose) polymerase (PARP) enzymes.

Covina，2024年2月27日（环球通讯社）——“根据最近的研究，PARP抑制剂市场规模在2024年约为125亿美元，预计复合年增长率为18.30%，到2034年将达到670亿美元。”什么是PARP抑制剂？市场概述：PARP抑制剂是一类抑制聚（ADP-核糖）聚合酶（PARP）酶活性的药物。

These enzymes play a crucial role in repairing damaged DNA within cells. By inhibiting PARP enzymes, PARP inhibitors disrupt the ability of cancer cells to repair DNA damage, leading to cell death or sensitizing cancer cells to other treatments like chemotherapy or radiation therapy. PARP inhibitors are primarily used in the treatment of certain types of cancer, particularly those caused by mutations in the BRCA genes.

这些酶在修复细胞内受损的DNA中起着至关重要的作用。通过抑制PARP酶，PARP抑制剂破坏癌细胞修复DNA损伤的能力，导致细胞死亡或使癌细胞对化疗或放疗等其他治疗敏感。PARP抑制剂主要用于治疗某些类型的癌症，特别是由BRCA基因突变引起的癌症。

BRCA1 and BRCA2 genes are involved in repairing DNA damage, and mutations in these genes increase the risk of developing breast, ovarian, prostate, and other cancers. Get Access to Free Sample Research Report with Latest Industry Insights: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4668 *Note: PMI Sample Report includes, Overview & introduction of market studyRevenue and CAGR of market Drivers & Restrains factors of market Major key players in market Regional analysis of the market with a detailed graphDetailed segmentation in tabular form of market Recent development/news of market Opportunities & Challenges of Market  Top Leading Players in PARP Inhibitor Market: Genentech, Inc.AstraZeneca Plc. Johnson & Johnson GlaxoSmithKline plc. Pfizer Inc. Jiangsu Hengrui Medicine Co.

BRCA1和BRCA2基因参与修复DNA损伤，这些基因的突变会增加患乳腺癌，卵巢癌，前列腺癌和其他癌症的风险。获取免费样本研究报告，了解最新行业见解：https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4668*注：PMI样本报告包括：，市场研究概述和介绍市场驱动因素和市场抑制因素的Evenue和CAGR市场主要参与者的市场区域分析，以市场最新发展的表格形式进行详细的图表细分/PARP抑制剂市场顶尖参与者的市场机遇和挑战新闻：Genentech，Inc.AstraZeneca Plc。强生葛兰素史克公司。辉瑞公司江苏恒瑞医药有限公司。

Ltd Clovis Oncology Inc. AbbVie Inc.Bristol - Myers SquibbMerck KGaA Market Dynamics: Driving Factors: The rising prevalence of cancer worldwide is a .

有限公司Clovis Oncology Inc.AbbVie Inc.Bristol-Myers SquibbMerck KGaA市场动态：驱动因素：全球癌症患病率上升是一个。